Health Advisory & Recovery Team (HART)

… Early analysis has demonstrated several concerning anomalies but crucially it has revealed that the efficacy data was not what was sold.

… Pfizer set out in its protocol that efficacy would be measured based on PCR positive test results in symptomatic individuals and, as a secondary measure, N-antibody levels showing who had been infected.